Back to Market Feed

Product Information

CIMZIA 2X200 MG/ML(X3)START KT is a brand product labeled by UCB, Inc., priced at $6072.5137 per EA under NDC 50474071081. Its NADAC has been published 96 times since Jul 17, 2024.

CIMZIA 2X200 MG/ML(X3)START KT

certolizumab pegol
$6072.5137per EA

Strength

200 mg/mL

Manufacturer

UCB, Inc.

NDC

50474071081

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

1/1/2026

Active Ingredients

CERTOLIZUMAB PEGOL

Approval Type

Biologic (BLA)

FDA Application

BLA125160

On Market Since

5/14/2009

Pharmacological Classes

Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price Statistics

The NADAC for CIMZIA 2X200 MG/ML(X3)START KT has been published 96 times since Jul 17, 2024, and over the history we have for it it has risen 10.1%. The table below summarizes its recorded NADAC range and movement.

Current price$6072.5137 per EA
All-time high$6072.5137 (May 13, 2026)
All-time low$5512.3676 (Aug 21, 2024)
52-week high$6072.5137
52-week low$5783.3464
Median price$5783.3464
Average price$5767.3385
Largest weekly change+5.0% (Jan 14, 2026)
Weeks tracked96
Tracking sinceJul 17, 2024

Price History

1W

N/A

1M

N/A

3M

N/A

6M

0.0%

1Y

+5.0%

3Y

N/A

5Y

N/A

All

+10.1%

Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

CIMZIA 2X200 MG/ML SYRINGE KIT
Brand
50474071079•UCB, Inc.
$6094.0250
+0% more

Related Drugs

Same classification

REMICADE 100 MG VIAL
Brand
57894003001•Janssen Biotech, Inc.
$1135.9660
per EA
ENBREL 50 MG/ML SYRINGE
Brand
58406002104•Immunex Corporation
$2080.6750
per ML
ENBREL 50 MG/ML MINI CARTRIDGE
Brand
58406004404•Immunex Corporation
$2080.9950
per ML
ENBREL 50 MG/ML SURECLICK
Brand
58406003204•Immunex Corporation
$2083.6232
per ML
ENBREL 25 MG/0.5 ML SYRINGE
Brand
58406001004•Immunex Corporation
$2086.2042
per ML
SIMPONI 100 MG/ML PEN INJECTOR
Brand
57894007102•Janssen Biotech, Inc.
$7446.2126
per ML
SIMPONI 50 MG/0.5 ML PEN INJEC
Brand
57894007002•Janssen Biotech, Inc.
$12909.9420
per ML
SIMPONI 50 MG/0.5 ML SYRINGE
Brand
57894007001•Janssen Biotech, Inc.
$12977.2440
per ML

Frequently asked questions

What is the NADAC price of CIMZIA 2X200 MG/ML(X3)START KT?

The current National Average Drug Acquisition Cost (NADAC) for CIMZIA 2X200 MG/ML(X3)START KT, manufactured by UCB, Inc., is $6072.5137 per EA (NDC 50474071081), effective May 13, 2026.

How has the price of CIMZIA 2X200 MG/ML(X3)START KT changed over time?

Over the history we have for it, the NADAC for CIMZIA 2X200 MG/ML(X3)START KT has risen 10.1%. It has been tracked across 96 weekly CMS publications since Jul 17, 2024.

What are the highest and lowest recorded NADAC prices for CIMZIA 2X200 MG/ML(X3)START KT?

Since Jul 17, 2024, the NADAC for CIMZIA 2X200 MG/ML(X3)START KT has ranged from a low of $5512.3676 (Aug 21, 2024) to a high of $6072.5137 (May 13, 2026), with a median of $5783.3464 per EA.

Are there cheaper alternatives to CIMZIA 2X200 MG/ML(X3)START KT?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CIMZIA 2X200 MG/ML(X3)START KT in a comparable dosage form, but none are currently priced below it.

Who manufactures CIMZIA 2X200 MG/ML(X3)START KT?

CIMZIA 2X200 MG/ML(X3)START KT (NDC 50474071081) is labeled by UCB, Inc., and CMS classifies it as a brand product.